A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis

Author： Jo Jae-Cheol   Hong Yong   Kim Kyu-Pyo   Lee Jae-Lyun   Lee Jeeyun   Park Young   Kim Sun   Ryu Jin-Sook   Lee Jong-Seok   Kim Tae  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 369-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

By Hersh Evan   O’Day Steven   Powderly John   Khan Khuda   Pavlick Anna   Cranmer Lee   Samlowski Wolfram   Nichol Geoffrey   Yellin Michael   Weber Jeffrey  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 489-498

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

By von Delius Stefan   Eckel Florian   Wagenpfeil Stefan   Mayr Martina   Stock Konrad   Kullmann Frank   Obermeier Florian   Erdmann Johannes   Schmelz Renate   Quasthoff Stefan   Adelsberger Helmuth   Bredenkamp Rainer   Schmid Roland   Lersch Christian  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study

By Blais Normand   Camidge D.   Jonker Derek   Soulières Denis   Laurie Scott   Diab Sami   Ruiz-Garcia Ana   Thall Aron   Zhang Ke   Chao Richard   Chow Laura  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1487-1498

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite